1. Home
  2. PHAT vs SVC Comparison

PHAT vs SVC Comparison

Compare PHAT & SVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • SVC
  • Stock Information
  • Founded
  • PHAT 2018
  • SVC 1995
  • Country
  • PHAT United States
  • SVC United States
  • Employees
  • PHAT N/A
  • SVC N/A
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • SVC Real Estate Investment Trusts
  • Sector
  • PHAT Health Care
  • SVC Real Estate
  • Exchange
  • PHAT Nasdaq
  • SVC Nasdaq
  • Market Cap
  • PHAT 465.0M
  • SVC 453.3M
  • IPO Year
  • PHAT 2019
  • SVC N/A
  • Fundamental
  • Price
  • PHAT $5.67
  • SVC $2.69
  • Analyst Decision
  • PHAT Strong Buy
  • SVC Buy
  • Analyst Count
  • PHAT 4
  • SVC 2
  • Target Price
  • PHAT $23.00
  • SVC $5.25
  • AVG Volume (30 Days)
  • PHAT 1.0M
  • SVC 1.5M
  • Earning Date
  • PHAT 03-06-2025
  • SVC 02-26-2025
  • Dividend Yield
  • PHAT N/A
  • SVC 1.49%
  • EPS Growth
  • PHAT N/A
  • SVC N/A
  • EPS
  • PHAT N/A
  • SVC N/A
  • Revenue
  • PHAT $26,270,000.00
  • SVC $1,884,419,000.00
  • Revenue This Year
  • PHAT $7,453.23
  • SVC N/A
  • Revenue Next Year
  • PHAT $226.38
  • SVC N/A
  • P/E Ratio
  • PHAT N/A
  • SVC N/A
  • Revenue Growth
  • PHAT N/A
  • SVC N/A
  • 52 Week Low
  • PHAT $5.21
  • SVC $2.29
  • 52 Week High
  • PHAT $19.71
  • SVC $7.73
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 39.59
  • SVC 48.69
  • Support Level
  • PHAT $5.50
  • SVC $2.55
  • Resistance Level
  • PHAT $6.21
  • SVC $2.69
  • Average True Range (ATR)
  • PHAT 0.40
  • SVC 0.13
  • MACD
  • PHAT 0.07
  • SVC -0.01
  • Stochastic Oscillator
  • PHAT 38.69
  • SVC 43.24

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About SVC Service Properties Trust

Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its hotel investment unit and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza Hotels & Resorts, and Hyatt Place.

Share on Social Networks: